Content » Vol 97, Issue 2

Short communication

Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors

Gamze Erfan, Susana Puig, Cristina Carrera, Ana Arance, Lydia Gaba, Ivan Victoria, Adriana Garcia-Herrera, Llucia Alos, Josep Malvehy
DOI: 10.2340/00015555-2488

Abstract

Abstract is missing (Short communication)

Significance

Related articles

Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al.

Supplementary content

Figure S1
Table SI

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.